Journals / Eurasian Journal of Family Medicine / 2019 / Cilt: 8 - Sayı: 1

A Wegener Granulomatosis Case Presented with Arthralgia

Artralji ile Başvuran Bir Wegener Granülamatozu Olgusu

Pages
45–50
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For thefirst three days 1 gr pulse and by the fourth day 1 mg/kg methylprednisolone and cyclophosphamide treatment was applied

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Granulomatosis with polyangitis (GPA/WG) (previously known as Wegener granulomatosis) is a multisystemsystemic necrotizing non-caeseating granulomatous vasculitis affecting small to medium sized arteries, capillaries andveins, with a predilection for the respiratory system and kidneys.
📊
Key Findings & Data:The average incidence of this disease is 40-55. 90% of theWG patients have pulmonary involvement.
💡
Conclusion & Impact:For thefirst three days 1 gr pulse and by the fourth day 1 mg/kg methylprednisolone and cyclophosphamide treatment was applied
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Granulomatosis with polyangitis (GPA/WG) (previously known as Wegener granulomatosis) is a multisystemsystemic necrotizing non-caeseating granulomatous vasculitis affecting small to medium sized arteries, capillaries andveins, with a predilection for the respiratory system and kidneys. The average incidence of this disease is 40-55. 90% of theWG patients have pulmonary involvement. Wegener Granulomatosis is a disease with high mortality when its diagnosisand treatment is delayed. Although WG may have symptoms such as hemoptysis and hematuria, it should be noted that itmay present with severe arthralgia and arthritis which may be in many connective tissue diseases and vasculitis. Malepatient, 52 years old. Analgesic treatment was applied when he came to the center due to arthralgia two months ago,however, there was no change in his complaints and intra-articular injection treatment was applied on left knee and bothshoulders. The symptoms did not regress and the patient lost 20 kg within the last two months. In urine analysis, 14-15erythrocyte and 10-15 leucocyte detected in every field; 1 positive detected. The patient was hospitalized in order to makefurther examination upon the determination of CRP: 61 mg/L and ESR: 82 mm/hr in the next polyclinic control after threedays. In the kidney biopsy report, “Pauci-immun glomerulonephritis” was primarily considered in the phenomenon. For thefirst three days 1 gr pulse and by the fourth day 1 mg/kg methylprednisolone and cyclophosphamide treatment was applied

Özet

Wegener Granülomatozu özellikle üst solunum yolları, akciğer ve böbrekler olmak üzere, tüm organları tutabilen nekrotizan granülomatöz vaskülitik bir hastalıktır. Ortalama görülme yaşı 40-55 tir. Kadın ve erkek eşit etkilenir. Akciğer tutulumu Wegener granülomatozisli hastaların %90’ında mevcuttur. Wegener Granülomatozu, tanı ve tedavisi geciktiğinde, mortalitesi yüksek olan bir hastalıktır. WG’nin hemoptizi ve hematüri gibi semptomları olabileceği gibi; birçok konnektif doku hastalığı ve vaskülitte olabilen şiddetli artralji ve artritle de prezente olabilir. 52 yaşında erkek hasta. 2 ay önce başlayan eklemlerde ağrı şikayetiyle başvurduğu merkezde analjezik tedavisi uygulanmış ancak fayda görmemesi nedeniyle sol diz ve her iki omuzuna intraartiküler enjeksiyon tedavisi yapılmış. Şikayetleri gerilemeyen hastanın son 2 ayda 20kg kaybı olmuş. Tam idrar tahlilinde: her sahada 14-15 eritrosit ve 10-12 lökosit, protein; 1 pozitif saptandı. Hastanın 3 gün sonraki poliklinik kontrolünde CRP’si:61 mg/L, sedimantasyonu: 82 mm saptanması üzerine ileri tetkik amacıyla hospitalize edildi. Böbrek biyopsisi raporunda, ön planda “pauci-immun glomerulonefrit” düşünüldü. İlk 3 gün 1 gr pulse, 4. günden itibaren 1 mg/kg metilprednizolon tedavisi ve siklofosfamid tedavisi uygulandı.

🔖

Cite This Article

YILMAZ, D., KARATEMİZ, G., BORLU, F., TOPRAK, D. (2022). A Wegener Granulomatosis Case Presented with Arthralgia. Eurasian Journal of Family Medicine, Cilt: 8 - Sayı: 1, 45–50. https://ajindex.com/articles/508361

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Madhira S, Hamid QA, Prayaga SMN, Kolloju S. Limited Wegener’s granulomatosis with predominant otological presentation. Indian J Otolaryngol Head Neck Surg 2011;63(Suppl 1):4-5
  2. Ozseker F, Guneylioglu D, Bilgin S, Bayram U. Wegener’s granulomatosis: two cases with the review of the cases reported in Turkey. Turkish Thoracic J 2002;3(1):109-12
  3. Fraser RS, Müller NL, Colman N, Pare PD. Diagnosis of diseases of the chest. 4 th ed. USA: Saunders Company; 1999:1489-532
  4. Lillaz J, Bernardini S, Algros MP, Bittard H, Kleinclauss F. Wegener's granulomatosis: a rare cause of hydronephrosis. Case Rep Med 2011;2011:814794. doi: 10.1155/2011/814794 5. Müller S, Eljack S, DelGaudio JM. Clinical pathologic conference case 1: Wegener’s granulomatosis. Head Neck Pathol 2011;5(3):268–72
  5. Akkalyoncu B, Ozturk A, Gozu A, Demirag F, Samurkasoglu B. Wegener granulomatosis: a case report. Respiratory Diseases 2000;11:100-3
  6. Allen SD, Harvey CJ. Imaging of Wegener's granulomatosis. Br J Radiol 2007;80(957):757–65
  7. Schucany WG. Wegener's granulomatosis presenting as a large solitary cavitary mass Proc (Bayl Univ Med Cent) 2010;23(2):171–2
  8. José RJ, Dilworth JP, Cleverley J, Young M, Stratton R, Lipman M. Wegener's granulomatosis with multiple pulmonary nodules – diagnostic difficulties. JRSM Short Rep 2010;1(4):34
  9. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116(6):488–98
  10. Pretorius ES, Stone JH, Hellman DB, Fishman EK. Wegener's granulomatosis: CT evolution of pulmonary parenchymal findings in treated disease. Crit Rev Comput Tomogr 2004;45(1):67–85
  11. Screaton NJ, Sivasothy P,Flower CDR, Lockwood CM. Tracheal involvement in Wegener’s granulomatosis: evaluation using spiral CT. Clinical Radiology 1998;53(11):809-15
  12. Papiris SA, Manoussakis MN, Drosos AA. Imaging of thoracic Wegener’s granulomatosis: the computed tomographic appearance. Am J Med 1992;93(5):529-36
  13. See CQ, Jaffe HA, Schraufnagel DE. Dyspnea and hemoptysis develop in a young man with prostitis. Chest 2005;128(5):3625–8
  14. DeRemee RA. Pulmonary vasculitis. In: Fishman AP (Ed.). Fishman’s Pulmonary Diseases and Disorders. New- York: Mac-Graw-Hill Companies; 1998:1357-74
  15. Fraser RS, Müller NL, Colman N, Paré PD. Diagnosis of diseases of the chest. 4th ed. USA: Saunders Company; 1999:1489-532
  16. Carol AL, Gary SH. Wegener’s granulomatosis. Thorax 1999;54:629-37. 18.